Where Tech Meets Bio

Where Tech Meets Bio

Home
Weekly Highlights
Deep Dives
Sponsored Features
About
Weekly Tech+Bio Highlights #75: Lilly's Supercomputer, FDA's One-Trial Shift, and China Deals Get Pricey
Generate:Bio's $400M IPO, federated ADMET modeling across five pharma companies, Gilead's $7.8B CAR-T buyout, and an $80M AI-enabled brain health clinic…
 • BiopharmaTrend and Roman Kasianov
Cancer as a Data Problem: What AI Is Doing in Oncology
We track what has moved from promise to proximate execution, from AI-assisted candidate design with 2026 trial targets to agentic workflows that aim to…
 • BiopharmaTrend
Weekly Tech+Bio Highlights #74: Big Pharma AI Tie-Ups Lean Toward Real-World Data
Quick run of pharma-AI collaborations, a new startup based on Google's cell sentence tech, and $100 genome sequencing from San Diego
 • BiopharmaTrend and Roman Kasianov
Five Genomics Watchpoints for 2026
Industrial functional genomics, modular gene editing, embryo ranking, falling sequencing costs, and scaled DNA synthesis start to connect into one…
 • BiopharmaTrend
Weekly Tech+Bio Highlights #72-73: Mid-Month Rundown
Mid-February highlights across AI drug discovery, gene therapy lane, IPO and M&A watch, and a few broader ecosystem notes
 • BiopharmaTrend and Roman Kasianov
Join 11k+ biotech industry professionals tracking strategy signals in the 'techbio' space
Recommendations
AI Supremacy
AI Supremacy
Michael Spencer
The Connected Ideas Project
The Connected Ideas Project
Alexander Titus
Special Competitive Studies Project
Special Competitive Studies Project
SCSP
Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Alex Zhavoronkov
Molecules & Empires
Molecules & Empires
Andrii Buvailo, PhD

Recent posts

View all
New-Modality Drugs Behind Today’s Big Headlines
How advanced therapeutics are solving “undruggable” biology and creating industry’s most valuable assets
 • BiopharmaTrend
Five Women Shaping the AI-Life Science Stack: International Day of Women and Girls in Science Special
On this UN observance, we profile five women building the AI-driven life sciences stack from discovery to clinic, while examining persistent gender gaps…
 • BiopharmaTrend
Big Pharma’s China Deal Wave & 12 Companies on Our Radar
A snap look at some of the deal dynamics and company platforms pulling global pharma toward China
 • BiopharmaTrend
How 2026 Started: First-Weeks Readout on AI, Pharma, & Policy
Early-year overview spanning virtual cell modeling, AI workflow plumbing in R&D and healthcare, obesity-driven capital and licensing, patent-cliff…
 • BiopharmaTrend
The latest from
Roman Kasianov
Weekly Tech+Bio Highlights #75: Lilly's Supercomputer, FDA's One-Trial Shift, and China Deals Get Pricey
User's avatar
BiopharmaTrend
Weekly Tech+Bio Highlights #75: Lilly's Supercomputer, FDA's One-Trial Shift, and China Deals Get Pricey
User's avatar
Andrii Buvailo, PhD
Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape
User's avatar
© 2026 BiopharmaTrend (BPT Analytics Ltd) · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture